IntegraGen Liquidation Is Suspended Pending Appeal

• IntegraGen’s sale to ABL Diagnostics and liquidation are suspended following prosecutors’ appeals against the October 9, 2026, court rulings.
• Operations continue under court-supervised restructuring pending a decision by the Paris Court of Appeal.
• Updated cash forecasts indicate sufficient funding to continue operations through at least the end of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IntegraGen SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261026944553) on October 26, 2026, and is solely responsible for the information contained therein.